Worth reading
78Important
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
8463000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause)
Who receives how much8,463,000Shares
Shares delivered during the month under review: 8,463,000 shares (new shares); transferred treasury shares: none
EVO FUND (allottee of the 39th Stock Acquisition Rights)
The lower thin line represents the existing number of shares to which these shares will be added.
Existing Shares and Increase
+10.00%Rate of increase
84,638,408 shares93,101,408Shares
10.0% (exercise ratio subject to the exercise restriction; 8,463,000 shares delivered during the month under review divided by 84,638,408 issued shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the month under review were ¥21.0, ¥22.0, ¥24.0 and ¥33.0. The lower limit under the adjustment clause was not disclosed.
Number of Stock Acquisition Rights
Total issued: 600,000 rights; unexercised as of 1 June 2026: 600,000 rights; unexercised as of the end of June 2026: 515,370 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restriction under Article 434 of the Listing Regulations. The exercise ratio subject to the exercise restriction was below 10.0%.
Most recent equity financing
Issuance of the 39th Stock Acquisition Rights through a third-party allotment (with Exercise Price Adjustment Clause) and execution of an agreement for the purchase of the stock acquisition rights, announced on 15 May 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | Shares delivered during the month under review: 8,463,000 shares (new shares); transferred treasury shares: none |
| Intended allottee | EVO FUND (allottee of the 39th Stock Acquisition Rights) |
| Dilution Rate | 10.0% (exercise ratio subject to the exercise restriction; 8,463,000 shares delivered during the month under review divided by 84,638,408 issued shares) |
| Total number of issued shares | 84,638,408 shares (as of 1 June 2026) → 93,101,408 shares (calculated by simply adding the number of shares delivered during the month under review) |
| Exercise price | Exercise prices during the month under review were ¥21.0, ¥22.0, ¥24.0 and ¥33.0. The lower limit under the adjustment clause was not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 600,000 rights; unexercised as of 1 June 2026: 600,000 rights; unexercised as of the end of June 2026: 515,370 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restriction under Article 434 of the Listing Regulations. The exercise ratio subject to the exercise restriction was below 10.0%. |
| Most recent equity financing | Issuance of the 39th Stock Acquisition Rights through a third-party allotment (with Exercise Price Adjustment Clause) and execution of an agreement for the purchase of the stock acquisition rights, announced on 15 May 2026 |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.